Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-15

FDA Approved: FERUMOXYTOL — Original Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a generic version of ferumoxytol from Sandoz (Original Application), providing a generic option for iron deficiency anemia in patients with chr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FERUMOXYTOL (ferumoxytol)

Snippet

ORIG AP for FERUMOXYTOL (FERUMOXYTOL)